What is the recommended dose of melatonin (N-acetyl-5-methoxytryptamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Melatonin

Based on current evidence, melatonin is typically administered at doses of 2-5 mg for adults, with 3 mg being a common starting dose, though the American Academy of Sleep Medicine suggests against using melatonin for primary insomnia in adults. 1, 2

Adult Dosing Recommendations

  • The American Academy of Sleep Medicine recommends a dose of 5 mg of melatonin taken between 19:00-21:00 for adults with Delayed Sleep-Wake Phase Disorder (DSWPD) 2
  • For general sleep disorders in adults, a starting dose of 3 mg immediate-release melatonin is suggested, with dose titration in 3 mg increments if needed 2, 3
  • For elderly patients (>55 years), a lower dose of 2 mg prolonged-release melatonin has shown some benefit 2, 4
  • The American Academy of Sleep Medicine suggests against using melatonin at 2 mg doses for primary insomnia in adults (weak recommendation) 1

Pediatric Dosing Recommendations

  • For children with DSWPD without comorbidities, a weight-based dose of 0.15 mg/kg taken 1.5-2.0 hours before habitual bedtime is recommended 2, 3
  • For children with DSWPD and psychiatric comorbidities, fast-release melatonin at 3-5 mg is recommended (3 mg if <40 kg and 5 mg if >40 kg) 2, 3
  • Effective doses in children range from 0.5 to 3 mg according to research evidence 5

Dosage Forms and Timing

  • Immediate-release formulations appear more effective than slow-release formulations for sleep onset 2
  • Melatonin should be taken close to the target bedtime (typically 10pm to midnight) for optimal effectiveness 6
  • Commercial preparations commonly available include 3 mg tablets 7

Safety Profile and Side Effects

  • Melatonin is generally considered safe with few serious adverse effects reported 1, 8
  • Most common side effects include daytime sleepiness (1.66%), headache (0.74%), and other sleep-related effects (0.74%) 3
  • Higher doses (≥10 mg) appear to have a good safety profile but may increase minor adverse events such as drowsiness, headache, and dizziness 8
  • Caution is advised when prescribing to patients taking warfarin and to patients with epilepsy due to potential interactions 1, 2, 3

Dosage Considerations for Specific Conditions

  • For jet lag prevention, doses between 0.5 and 5 mg are similarly effective, with 5 mg providing faster sleep onset and better sleep quality than 0.5 mg 6
  • For elderly patients with insomnia, doses ranging from 0.5 mg to 6 mg have been studied, with significant decreases in sleep latency observed 9
  • A recent study showed that 5 mg melatonin significantly increased sleep efficiency in older adults during both biological day and night 4

Important Clinical Considerations

  • Choose reputable formulations (United States Pharmacopeial Convention Verified) for more reliable dosing 1
  • Lower doses may be more effective than higher doses due to potential receptor desensitization 2
  • Morning grogginess and "hangover" effects are more commonly reported with higher doses 2
  • For adults with DSWPD, a treatment duration of 28 days has shown efficacy 2

Pitfalls and Caveats

  • Timing of melatonin dose is critical - if taken too early in the day, it may cause sleepiness and delay adaptation to local time 6
  • The American Academy of Sleep Medicine suggests against using melatonin for primary insomnia in adults, indicating limited efficacy for this specific condition 1
  • Quality control of melatonin products varies widely, affecting the reliability of stated doses 1
  • Evidence for long-term safety is limited, as many studies are of short duration 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Melatonin Treatment for Sleep Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Melatonin Use for Sleep Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Melatonin for the prevention and treatment of jet lag.

The Cochrane database of systematic reviews, 2002

Research

Melatonin in elderly patients with insomnia. A systematic review.

Zeitschrift fur Gerontologie und Geriatrie, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.